CLINICAL_TRIALS
ClinicalTrials.gov record update
Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03426865
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:28.700001+00:00
- Published At
- 2025-08-11T00:00:00+00:00
- Record Updated At
- 2025-08-11
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Testis Cancer", "Germ Cell Tumor", "Testicular Cancer", "Germ Cell Tumor of Testis", "Germ Cell Tumor, Testicular, Childhood", "Testicular Neoplasms", "Testicular Germ Cell Tumor", "Testicular Yolk Sac Tumor", "Testicular Choriocarcinoma", "Testicular Diseases", "Germ Cell Cancer Metastatic", "Germ Cell Neoplasm of Retroperitoneum", "Germ Cell Cancer, Nos"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-08-11"- protocolSection.identificationModule.nctId
"NCT03426865"- protocolSection.identificationModule.officialTitle
"Anti-1-amino-3-18F-flurocyclobutane-1-carboxylic Acid (Axumin) Positron Emission Tomography/Computed Tomography Prior to Retroperitoneal Lymph Node Dissection for Testicular Cancer"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.